Click here to view online. Add this email to your safelist.
Advancing genetic targets in dilated cardiomyopathy
16 April 2026
What Science Can Do: New story alert
AstraZeneca is pioneering a new era in haematology care, advancing precision therapies for multiple myeloma, lymphoma and leukaemia to improve outcomes and reduce treatment burden.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
